I am pleased to congratulate renowned scientist Deepak Srivastava, MD, on his new role as the third president of the Gladstone Institutes.

Deepak is recognized for his contributions in the fields of cardiology and stem cell biology. His laboratory has been a leader in deciphering how embryonic stem cells form a heart, learning how that process is genetically disrupted in heart disease, and using that knowledge to regenerate damaged hearts. Deepak will maintain his research laboratory activities at Gladstone during his tenure as president.

Gladstone, a nonprofit life sciences research institution, shares a decades-long academic affiliation with UCSF. The Gladstone mission closely aligns with ours – to bring together visionary scientists with the technology to treat unsolved diseases and to train the next generation of researchers.

A pediatric cardiologist, Deepak himself is an example of our pioneering trainees having completed his residency in pediatrics at UCSF Medical Center in 1992. He then served fellowships at both the Children’s Hospital of Harvard Medical School and MD Anderson Cancer Center before joining the Gladstone Institutes in 2005.

Prior to being named president, Deepak was a senior investigator and director of the Gladstone Institute of Cardiovascular Disease, Younger Family Director, and director of the Roddenberry Stem Cell Center.

Deepak succeeds R. Sanders “Sandy” Williams, MD, who as Gladstone president from 2010 to 2017 founded several biotechnology companies based on the translation of discoveries into the development of novel therapeutics. Sandy will continue his affiliation with Gladstone.